SDAC: Clinical Trials Brown Bag Discussion Series

Title Date Presenter
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: Context and Controversy Wednesday, December 4, 2013 -
12:00pm to 1:00pm

Marian Fisher

PKCS-9 Monoclonal Antibodies for Treatment of High LDL-Cholesterol Wednesday, November 6, 2013 -
12:00pm to 1:00pm

Kevin Buhr

Issues from the FDA Advisory Committee Meeting to Review the New Drug Application (NDA) for the use of Tovaptan to Treat Autosomal Dominant Polycystic Kidney Disease (ADPKD) Wednesday, October 2, 2013 -
12:00pm to 1:00pm

Robin Bechhofer

Studies from the SDAC Archives: PROMISE and PRAISE Wednesday, May 1, 2013 -
12:00pm to 1:00pm

Jan Feyzi

The Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF) Trial: Overview and Results Wednesday, April 3, 2013 -
12:00pm to 1:00pm

Melissa Schultz

Placebo Effects Tuesday, March 19, 2013 -
12:00pm to 1:00pm

Allison Furey

Recent developments in Rheumatoid Arthritis Wednesday, January 23, 2013 -
12:00pm to 1:00pm

Gabriel Nicholas

Major Depressive Disorder (in Children and Adolescence), Overview of the Pristiq Phase III Pediatric Trials Wednesday, December 5, 2012 -
12:00pm to 1:00pm

Scott Diegel

Pages

Additional Information

Jeanne McCabe
Clinical Trials Program Manager
mccabe [at] biostat.wisc.edu
608-265-6702